Anti-coagulant [EPC]

1052 reported adverse events

Drugs of this class: ARGATROBAN

Drugs of the Anti-coagulant [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BURKITT'S LYMPHOMA STAGE IV 1 0.2500
1 OESOPHAGEAL INTRAMURAL HAEMATOMA 7 0.1795
2 BILE OUTPUT 1 0.1250
3 COAGULATION TIME PROLONGED 64 0.0543
4 ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL 8 0.0421
5 COAGULATION TIME ABNORMAL 9 0.0369
6 HEPARIN-INDUCED THROMBOCYTOPENIA 116 0.0329
7 HEPARIN-INDUCED THROMBOCYTOPENIA TEST POSITIVE 2 0.0323
8 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 10 0.0311
9 VASCULAR GRAFT THROMBOSIS 2 0.0303
See all enriched reactions for Anti-coagulant [EPC]